CiteFacts · FDA Drug Shortages · FDA source
Flurazepam Hydrochloride Capsule
Status
FDA currently lists this ingredient in shortage.
This is nationwide FDA status, not local pharmacy inventory. CiteFacts does not provide medical, treatment, substitution, or dosing advice.
FDA package and manufacturer records
| Company | Presentation | FDA availability field | FDA update |
|---|---|---|---|
| Chartwell Molecular Holdings LLC | Flurazepam Hydrochloride, Capsule, 15 mg (NDC 62135-736-30) | Available | 08/04/2026 |
| Chartwell Molecular Holdings LLC | Flurazepam Hydrochloride, Capsule, 15 mg (NDC 62135-736-90) | Available | 08/04/2026 |
| Chartwell Molecular Holdings LLC | Flurazepam Hydrochloride, Capsule, 30 mg (NDC 62135-737-30) | Available | 08/04/2026 |
| Chartwell Molecular Holdings LLC | Flurazepam Hydrochloride, Capsule, 30 mg (NDC 62135-737-90) | Available | 08/04/2026 |
| Rising Pharma Holdings, Inc. | Flurazepam Hydrochloride, Capsule, 15 mg (NDC 0378-4415-01) | Unavailable | 06/03/2026 |
| Rising Pharma Holdings, Inc. | Flurazepam Hydrochloride, Capsule, 30 mg (NDC 0378-4430-01) | Unavailable | 06/03/2026 |
Source facts
Grouped generic ingredient: Flurazepam Hydrochloride Capsule · 6 package records · Latest FDA row update: 08/04/2026
Therapeutic categories: Neurology, Oncology, Other
Dosage forms: Capsule
Routes: ORAL
Open FDA source data · JSON · Markdown
FDA is authoritative. Source retrieved 2026-08-22T15:54:11+00:00. Derived grouping is documented in this record's derivations.